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The catalytic versatility of flavins encompasses the ability to catalyze one and 
two electron redox processes as well as dioxygen activation. In flavoenzymes, 
protein-cofactor interactions modulate flavin chemistry enabling these enzymes to 
perform a diverse set of biological roles. Flavin analogs, such as deoxyflavins, 
provide a convenient method for identifying which polar contacts to FMN are 
necessary for enzymatic activity.   
Iodotyrosine deiodinase (IYD) is responsible for the deiodination of 
byproducts from thyroxine biosynthesis (mono- and diiodotyrosine (MIT and DIT)) 
in the thyroid. A unique flavoenzyme, IYD, is one of few known aerobic enzymes 
able to catalysis reductive dehalogenation. Literature precedence for the deiodination 
mechanism of IYD has not been found. Detection of the flavin semiquinone (Flsq) 
intermediate during anaerobic reduction of IYD in the presence of substrate suggests 
deiodination occurs via two single electron transfer processes. Proposed one electron 
  
mechanisms for IYD involving formation of a substrate keto-tautomer are supported 
by the enzyme’s preference for the phenolate form of substrate during binding. 
Previous analysis of a co-crystal of IYD and MIT showed the involvement of 
substrate in extensive interactions with the FMN cofactor, including a hydrogen bond 
between the FMN ribityl 2ʹ-OH and the phenolic OH of MIT. This hydrogen bond has 
been hypothesized to activate substrate for deiodination.   
To probe the significance of the polar interaction between the ribityl 2ʹ-OH 
and the phenolic OH of MIT in IYD, 2-deoxyriboflavin was synthesized and 
enzymatically phosphorylated using riboflavin kinase. Reconstitution of human IYD 
(hIYD) with 2-deoxyFMN produced an enzyme with a significantly decreased 
affinity for MIT. Deiodinase activity was retained in 2-deoxyhIYD with a 10-fold 
decrease in catalytic efficiency. Detection of the Flsq was not observed during 
anaerobic reduction of 2-deoxyhIYD in the presence of mono-fluorotyrosine (MFT). 
The enzyme’s preference for the phenol versus phenolate form of substrate could not 
be determined due to the low solubility of DIT at concentrations necessary for pH 
dependent binding analysis. Removal of the ribityl 2ʹ-OH did not support turnover of 
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Chapter 1: Introduction 
1.1 The Chemistry of Flavoenzyme 
1.1.1 Cofactor with Diverse Activity 
 
The biological importance of flavin has been under investigation since its 
recognition as a component of the vitamin B complex1. Initially isolated from cow’s 
milk in 1879 by the English chemist A. Wynter Blyth as a bright yellow pigment, it 
was not until the mid-1930s that a chemical structure was determined in parallel by 
Richard Kuhn and Paul Karrer1. It was from that chemical structure (Figure 1.1) that 
the name riboflavin was derived, on the basis of its N10 ribityl side chain, yellow 
colored conjugated ring system and the compound’s classification as a vitamin.  
The biological active forms of riboflavin, flavin mononucleotide (FMN) and 
flavin adenine dinucleotide (FAD) were discovered to be necessary for enzymatic 
catalysis through the removal of the native cofactor and reconstitution with riboflavin 
in old yellow enzyme and D-amino acid oxidase1. These cofactors differ from 
riboflavin in their modification at the N10 ribtyl chain (Figure 1.1) where 
phosphorylation of the terminal 5ʹ-OH produces FMN. Further adenylation of FMN 












Figure 1.1 The chemical structure of flavin.  
 
In general, flavins are defined by their tricylic isoalloxazine ring system, 
comprised of a hydrophobic dimethylbenzene, a hydrophilic uracil ring and a central 
pyrazine ring (Figure 1.1). The isoalloxazine ring is the center of reactivity and 
responsible for the catalytic versatility of the cofactor that encompasses the ability to 
catalyze 1 and 2 electron redox processes as well as dioxygen activation 2, 3. Flavins 
can exist in major redox states with each state occurring as a neutral, anionic and 
cationic species 4. Of these nine variants, only five are physiologically relevant: the 
neutral flavoquinone (Flox), the neutral and anionic flavohydroquinone (Flred, Flred
-), 
and the neutral and anionic flavosemiquinone (Flsq, Flsq
-) (Scheme 1.1) 4, 5. Reduction 
of the fully oxidized Flox can occur via one of two pathways: 1) a single two electron 
transfer or 2) two sequential one electron transfers, forming a stable radical 
intermediate at the either the N5 or C4a  position of the isoalloxazine ring (Figure 
1.1) 6. Each state can be differentiated by way its characteristic optical spectrum. The 




absorbance maximum around 500-600 nm and the anionic Flsq
- is red with an 
absorbance maximum around 370-400 nm. The Flred is colorless. 
 
 
Scheme 1.1 Physiologically relevant redox and protonation states of riboflavin. 
 
The Chemical Environment of Flavin Controls Redox Chemistry  
Studies on both free and protein bound flavin have shown that its redox 
properties can be fine-tuned by its surrounding chemical environment 6-11. For 
flavoenzymes, the presence of non-covalent interactions plays a substantial role in the 
modulation of cofactor chemistry, and therefore enzymatic catalysis. Interactions 




control the site of hydrogen transfer, the modes of electron transfer pathways and the 
modes of O2 reductive activation 
3, 12. Site directed mutagenesis and/or enzymatic 
reconstitution with chemical modification of flavin have helped to decipher which of 
the non-covalent interactions between the cofactor and apoprotein are critical for 
activity 1, 3, 12. The process of enzymatic reconstitution involves removal of the 
enzyme’s native cofactor and reinsertion of a flavin derivative, producing enzymes 
with different catalytic properties.  The protein environment surrounding the 
pyrimidine ring is particularly important in control of the flavin redox potential 7, 8. 
The N1 and N5 atoms at either end of the ethylenediamine linkage of the 
isoalloxazine nucleus, as well as their neighboring carbonyls groups (O2 and O4), are 
crucial for stabilization of the anionic and neutral forms of the semiquinone and 
hydroquinone states. For example, positively charged amino acid side chains near N1 
and O2 increase the redox potential of flavin as well as stabilize the anionic form of 
the reduced flavin, whereas negatively charged amino acid side chain have the 
opposite effect and decrease the redox potential 8, 11. This trend is seen in a number of 
flavoenzymes where the N1 position is in close proximity to protein residues such as 
a lysine or arginine 11 or even the flavin ribtyl side chain. Additionally, intraflavin 
hydrogen bonding between the 4ʹOH and N1 in human and bacterial electron transfer 
flavoproteins (ETFs) has been implicated in the stabilization of the  Flsq
- and Flred
- 
redox states of FAD 13. The N5 position of the isoalloxazine ring is also important for 
stabilization of the neutral Flsq and dioxygen activation 
14 15, 3. Hydrogen bonding at 
this position by donors such as lysine or threonine has been shown to active the 




Numerous reconstitution studies have confirmed the significance of N1 and 
N5 by utilizing 1-deaza and/or 5-deazaflavins analogs as mechanistic probes 2, 8, 17. 
Substitution of the N1 with carbon decreases the redox potential of this analog from -
208 mV to -280 mV, making it harder to reduce than the native flavin 18. However, 
this substitution does not eliminate the ability of 1-deaza analog to support both 1 and 
2 electron transfers 18.  In contrast, carbon substitution of the N5 converts the central 
pyrazine ring into a pyridine ring. This modification not only decreases the redox 
potential from -208 mV to -311 mV but also suppresses single electron transfer and 
converts this analog into a nicotinamide equivalent 18.   
The Ribose Chain of Flavin Affects Substrate Recognition and Activation 
Crystal structures of several flavoenzymes including old yellow enzyme 19, 
glutathione reductase 20, lipoamide dehydrogenase 21 and human monoamine oxidase 
B22 have shown networks of hydrogen bonding to the N10 ribityl chain hydroxyls, 
implying the significance of these groups for anchoring the cofactor and modulating 
catalytic activity. The 4ʹ-OH has been observed by x-ray crystallography to form an 
intraflavin hydrogen bond with N1 of FAD in human and bacterial ETFs 13. 
Elimination of the 4ʹ-OH-N1 hydrogen bond by reconstitution of the human ETF with 
4-deoxyFAD resulted in a 0.116 V decreased redox potential of the Flox/Flsq half 
reaction, making it difficult to reduce the cofactor in the presence of either 
xanthine/xanthine oxidase or sodium dithionite 13. These observations strongly 
suggest that the 4ʹ-OH is necessary for stabilization of the Flsq
-. 
Removal of the ribityl chain 2ʹ-OH can also have significant effects on 




dehydrogenase that promotes dehydrogenation of acyl CoAs from either β-oxidation 
cycle or amino acid metabolism 26, 27. Crystal structures of the medium chain acyl-
CoA dehydrogenase (MCAD) show the presence of two hydrogen bonds to the 
thioester carbonyl oxygen of acyl-CoA, one from the NH of Glu376 and the other 
from the 2ʹ-OH of FAD (Figure 1.2) 26. These interactions were hypothesized to 
lower the pKa of the acyl-CoA α proton as well as align acyl-CoA, FAD, and Glu376 
for dehydrogenation.  Reconstitution studies utilizing 2-deoxyFAD to eliminate the 
polar contact between 2ʹ-OH and the thioester carbonyl resulted in a 1.5 x 107 fold 
decrease in substrate dehydrogenation 28.  Additionally, studies with wild type 
MCAD and an acyl-CoA substrate analog also measured the effects of hydrogen 
bonding on substrate pKa and showed a 6 unit increase in pKa for the substrate when 
bound to native MCAD versus 2-deoxyFAD-MCAD (pKa ~5 for wild type MCAD; 
pKa ~11 for 2-deoxyFAD-MCAD) 
28.  This difference was attributed solely to the loss 
of substrate hydrogen bonding with the 2ʹ-OH, confirming the necessity of this 































Figure 1.2 Hydrogen bond of acyl-CoA with FAD ribityl 2ʹOH and Glu376 in 
medium chain acyl-CoA dehydrogenase (MCAD). PBD ID: 3MDE 26. 
 
1.1.2  Unusual Role of Flavoenzymes in Reductive Dehalogenation 
 
Efforts to correlate cofactor chemistry with mechanism of action led to a 
classification of flavin-dependent enzymes on the basis of their catalytic activity, with 
more than 90% of flavoenzymes classified as oxidoreductases 29. The chemical 
versatility of flavins support a range of biological processes including 
bioluminescence 30, photosynthesis 31, dehalogenation 32, 33¸ and halogenation 34, 35. Of 
the more than 300 known flavoenzymes, few are associated with reductive 
dehalogenation 36. As a result, mechanisms for reductive dehalogenation are often 
expanded to include aerobic systems, with tetrachlorohydroquinone dehalogenase and 




Tetrachlorohydroquinone dehalogenase (TD) from the soil bacterium 
Sphingobium chlorophenolicum, catalyzes the reductive dechlorination of 
tetrachlorohydroquinone (TCHQ) and trichlorohydroquinone (TriCHQ) in the 
biodegradation of the pentachlorophenol 37. The mechanism of this dechlorination has 
been proposed to start with the tautomeraztion of TCHQ to an electrophilic enone 
(Scheme 1.2). Nucleophilic attack of the enone by glutathione, results in the 
elimination of a chloride ion. The sulfur atom of the glutathionyl intermediate is then 
attacked by a neighboring cysteine residue, releasing TriCHQ.  A second glutathione 
is then hypothesized to regenerate the active site cysteine residue, completing the 
catalytic cycle (Scheme 1.2) 38, 39.   
 
Scheme 1.2 Proposed mechanism for the reductive dehalogenation of 
pentachlorophenol catalyzed by tetrachlorohydroquinone dehalogenase (TD). 
 
The second example, iodothyronine deiodinase (ID), is responsible for the 
reductive deiodination of the prohormone thyroxine (T4), converting it to the thyroid 
hormone, 3,3ʹ5 - triiodothyronine (T3) 
40. Similarly to TD, the propose mechanism of 
deiodination for ID, begins with tautomeraztion of T4 to a non-aromatic intermediate 
(Scheme 1.3) 40.  Nucleophilic attack of the C5ʹ iodide of T4 by an active site 




cycle is completed upon reduction of the selenoleyl iodide by substrate thiols, 
regenerating the active site selenocysteine and releasing iodide 40, 41.  
 
Scheme 1.3 Proposed mechanism for the reductive dehalogenation of thyroxine 
catalyzed by iodothyronine deiodinase (ID). 
  
As an important constituent of T3 and T4, iodide is indispensable to regulation 
of metabolism and energy balance, growth and development, and development of the 
nervous system 42. Therefore, access to this micronutrient is critical for mammalian 
health. However, iodide is scare in the environment and the majority of earth’s supply 
is found in the ocean 43. Nature has found a way to maintain iodide in the body 
through the action of another reductive dehalogenase, iodotyrosine deiodinase (IYD). 
 
1.2 IYD is a Flavoenzyme that Catalyzes Reductive Dehalogenation 
1.2.1 Iodide Salvage 
 
IYD is a mammalian flavoenzyme that catalyzes the reductive deiodination of 




transported by the Na/I symporter to the follicular cells of the thyroid where it is 
concentrated up to 40-fold over the levels found in the plasma (Figure 1.3) 44. This 
iodide is then transported across the apical membrane into the colloid where it is 
oxidatively coupled to tyrosine residues of thyroglobulin by thyroid peroxidase in the 
presence of H2O2 to form mono- and diiodotyrosines (MIT and DIT, respectively). A 
second oxidative coupling, also catalyzed by thyroid peroxidase, then couples 
adjacent iodotyrosines to produce thyroglobulin bound iodothyronines, T3 and T4. 
Secretion of the thyroid stimulating hormone is required for endocytosis of the 
iodinated thyroglobulin into the follicular cell where it is hydrolyzed to release T4/T3 












Figure 1.3 The biosynthesis of the thyroid hormones, T4 and T3, in the thyroid 





Iodination of thyroglobulin typically produces approximately 7 MIT and 6 
DIT per molecule of T4/T3
47.  Excretion of these byproducts as waste from the body 
would increase the physiological demand for iodide. While MIT and DIT are direct 
precursors to the thyroid hormones, these compounds cannot be directly reused for 
biosynthesis of T4 and T3, as thyroglobulin requires free iodide. Instead these 
byproducts must be metabolized by IYD to release free iodide that can then be 
recycled for production of more T4 and T3 (Scheme 1.4).  
 
Scheme 1.4 Dehalogenation of mono- and diiodotyrosine catalyzed by IYD. 
 
Salvage of iodide by IYD is crucial for proper thyroid function as deficiencies 
in iodide homeostasis result in a number of health disorders, including 
hypothyroidism and goiter as the classic examples. The most detrimental of these 
consequences occur during fetal and adolescent brain development 48. The IQ of 
children with iodide deficiency is on average 15 points lower than those with 
adequate iodide nutrition 48. The World Health Organization has listed iodine 
deficiency as the most preventable cause of mental impairment worldwide 49. 
Although the introduction of iodide via iodized salt has significantly helped to 
decrease iodide deficiency, it remains a global problem. Insufficient dietary iodine is 




1.2.2 Characterization of IYD as a nitro-FMN reductase 
 
The first reports of a thyroidal deiodinase specific for MIT and DIT were 
made by Roche et al in the early 1950s 50, 51. Reports of similar deiodinase activity in 
various tissue homogenate samples including those from thyroid, liver and kidney 
soon followed 52. Once Rosenberg was able to partially purify the IYD from bovine 
thyroid, it was found to be a FMN dependent enzyme 53, 54. The gene encoding for 
IYD, DEHAL1, was identified a few decades later 55-57. Discovery of DEHAL1 
confirmed clinical hypotheses from the 1950s that mutations of IYD were responsible 
for certain forms of congenital hypothyroidism and goiter 58-60. Shortly thereafter, 
IYD was assigned as a member of the nitro-FMN reductase structural superfamily on 
the basis of peptide sequence homology 61.  This assignment made IYD the first 
mammalian member of this superfamily that had previously been identified only in 
bacteria.  
1.2.3 Comparison of IYD within nitro-FMN reductase Superfamily 
 
Structural Comparison  
Classification of IYD of as a nitro-FMN reductase generated interest in the 
enzyme’s molecular structure in order to understand the mechanism of its reductive 
dehalogenation. Advances in protein expression and purification have led to the large 
scale production of IYD in Sf9 insect cells and E. coli 62. As a direct result, crystal 
structures for both the mouse and human IYD (mIYD and hIYD, respectively) have 
been solved 63, 64 revealing important structural details about the relationship between 
protein, cofactor and substrate that have been helpful in directing mechanistic studies. 




active site sitting at the dimer interface 63. The active site is comprised of residues 
from both subunits and forms a lid upon substrate binding (Figure 1.4) 63. These 
features are shared by all members of the nitro-FMN reductase superfamily.  
Figure 1.4 Crystal structure of hIYD (left) and its co-crystal with MIT. 
hIYD is shown in dark blue and purple. PBD ID: 4TTB, 4TTC 64. 
 
IYD and BluB form a Distinct Subgroup 
Several factors differentiate IYD and one other member, BluB, from the 
majority of the nitro-FMN reductase enzymes including active site lid formation and 
FMN protein interaction 63. Nitro-FMN reductase enzymes are divided into two 
subgroups based of the protein region used to form the active site lid. These two 
groups are represented by NADH oxidase (Thermus thermophilus), which forms its 
lid using a central α-helix region, and flavin reductase P (Vibrio harveyi), which uses 
a C-terminal extension (Figure 1.5A). Both IYD and BluB, however, utilize the same 
distinct α-helix region near the N-terminal to form their active site lid (Figure 1.5A), 
differentiating these enzymes from the two previously mentioned groups and creating 




interactions for IYD and BluB, especially around the FMN pyrimidine ring, are 
minimal compared to the rest of the superfamily (Figure 1.4B). BluB cannibalizes its 
FMN cofactor for the biosynthesis of the lower ligand of vitamin B12 
65.  Although the 
mechanism of this transformation is still unknown, the lack of flavin-protein 
















Figure 1.5 Comparison of IYD to nitro-FMN reductase superfamily.  
A) Alignment of the secondary structure for representative members of the nitro-
FMN reductase superfamily, highlighted in the box is the region used to form the 
active site lid. B) Comparison of the active site interaction of IYD, BluB, and FRP. 
Figure modified from 63. 
 
For IYD, active site interactions for flavin and protein are largely dependent 
on the presence of substrate. Upon substrate binding, hydrogen bonding between the 
zwitterionic amino acid MIT and three active site residues (Glu157, Tyr161, and 
Lys182 in mIYD) as well as the C3 carbonyl and N3 of the isoalloxazine ring (Figure 
1.6) form a bridge between FMN and the active site lid. The phenolic ring of MIT is 
observed to π – stack over the isoalloxazine ring of FMN. Another hydrogen bond is 
formed between phenolic hydroxyl group of MIT and the 2ʹ-OH of the FMN ribityl 




ring of MIT over FMN for proper stacking and positioning of the C-I bond of MIT 
over the C4a position of FMN.  Equivalent to the need for the FAD 2ʹ-OH of acyl 
CoA dehydrogenase to promote catalysis, the FMN 2ʹ-OH of IYD may also be 
necessary for its catalysis as well. Additionally, hydrogen bond donors Arg104 and 
Thr239 in hIYD positioned near the N1 and N5 of FMN were also observed. 
Hydrogen bonding to these positions has been known to play a role in stabilization of 
the Flsq 
8.  These interactions between protein, substrate and FMN have proven to be 
















Figure 1.6 Crystal structure of the active site of hIYD, highlighting the interaction 
between MIT, the protein and FMN. PBD ID: 4TTC 64. 
 
1.3 Proposed Mechanism for IYD 
While it is widely accepted that IYD deiodinates MIT and DIT via a reductive 
process 66, the mechanism of this deiodination is still not well understood. In vivo 




lost and dithionite is required for enzymatic reduction 53, 54. Precedence for aerobic 
reductive dehalogenation is limited to TD and ID. The mechanism for these, both 
depend on the use of an active site residue (cysteine or selenocysteine) during 
dehalogenation 39, 40. A mechanism was initial hypothesized for IYD but quickly 
abandon after site directed mutagenesis of C217A and C293A in mIYD proved that 
cysteine was not require for deiodination activity 67. This observation was later 
supported by the crystal structures of IYD that show the cysteine residues reside in 
regions away from the active site 63. The crystal structures of IYD also show no other 
nucleophilic amino acid residues within the active site 63, 64.  
As a flavoprotein, IYD is capable of reducing iodotyrosine via either a one or two 
electron transfer process. Within the active site, π – stacking of iodotyrosine over the 
N10 axis of FMN, aligns the C-I bond 3.65Å above the C4a-N5 position of the 
isoalloxazine ring, a sufficient distance for direct electron transfer from FMN to 
substrate 63. The C4a-N5 region of flavin is a key site radical formation as well as the 
site dioxygen activation in other flavoenzymes 2, 3.   EPR and UV-Vis measurements 
during the redox titration of IYD in the presence of substrate indicate formation of the 
neutral Flsq as monitored by an increasing absorbance at ~560 nm 
64, 68. This data 
strongly suggest that IYD catalyzes reductive dehalogenation via a one electron 
transfer process.  Two mechanisms have been proposed for this one electron 
reduction dehalogenation (Scheme 1.5)46. The first mechanism proceeds via radical 
aromatic substitution (SRN1) (Scheme 1.5A). Transfer of a single electron from Flred 
into the phenyl ring of MIT would generate an aromatic anion radical intermediate. 




iodide. Transfer of a second electron from Flsq and a proton would then yield tyrosine 
and Flox.  The second proposed mechanism involves an initial tautomerization of 
substrate to a non-aromatic ketone (Scheme 1.5B). Transfer of a single electron from 
Flred would then result in release of iodide, forming a tyrosyl radical. Addition of a 
second electron followed by proton transfer would complete the catalytic cycle to 
give tyrosine and Flox.  
 
Scheme 1.5 Proposed one electron transfer mechanisms for the reductive 
dehalogenation catalyzed by IYD. 
 
The role of the substrate protein hydrogen bonds have been explored using site 
directed mutagenesis studies with mIYD.  Mutation of the amino acid residues that 
make polar contact to the zwitterion of MIT have resulted in either a decrease 
(Y157F) or total loss (E153Q) of enzymatic activity62. Removal of the lysine 
hydrogen bond appeared to destabilization of protein structure as expression of a 
K178Q mutant gave 62, highlighting the importance of these interactions. These 
results have led to questions about the significance of the substrate hydrogen bond to 




1.4 Specific Aims 
This dissertation will address:  
1) Modified flavin analogs are an often used to explore the role of cofactor 
interactions for enzymatic catalysis. 2-deoxyFAD has been used as a mechanistic 
probe to identify the importance of hydrogen bonding to this position in 
flavoenzymes such as MCAD, where the ribityl 2ʹ-OH has been shown to be 
necessary for substrate activation.  The synthesis of 2-deoxyFMN was carried 
out to investigate the dependence of the 2ʹ-OH for reductive deiodination of IYD. 
2) Though most flavins are bound to the apoprotein through non-covalent 
interactions, the process necessary for cofactor removal can often be detrimental 
to the recovery of enzymatic activity. Characterization of hIYD reconstituted 
with both FMN and 2-deoxyFMN was performed determine the effects of 
reconstitution on IYD activity. The FMN reconstitution was used as a positive 
control to verify whether changes in the enzymatic activity of IYD were due to 
the reinsertion of the cofactor or disruption of the FMN-substrate hydrogen bond. 
3) The hydrogen bond between the FMN ribityl 2ʹ-OH and phenolic OH of MIT has 
been hypothesized to facilitate the tautomerization of MIT for deiodination by 
IYD. Additional, it is believed that this bond maybe necessary for substrate 
recognition. The role of this interaction was examined using an O-methyl MIT 
analog, which is unable to tautomerization to the proposed substrate keto-




Chapter 2: Preparation of a 2-DeoxyFMN Analog 
2.1 Introduction 
The extensive range of reactions catalyzed by flavoenzymes can be attributed to 
the chemical versatility of the flavin cofactor its capacity to catalyze both one and two 
electron transfer processes. The ability of specific flavoenzymes to promote these 
processes is controlled by the chemical environment surrounding the cofactor. To 
distinguish which feature controls enzymatic activity, the cofactor environment can 
be perturbed by either site directed mutagenesis of the protein or by chemical 
modification of either the substrate or cofactor.  
An extensive collection of flavin analogues have been created via organic 
synthesis 24, 69. These analogs have long been used to probes of features of 
flavoenzymes catalysis such as active site polarity, reaction stereochemistry and 
flavin electron transfer processes 7, 24 70. Analogs such as the 1-deaza and 5-
deazaflavins (Figure 2.1) have been used to differentiate between a 1 or 2 electron 
transfer process flavoenzymes such as isopentyl diphosphate isomerase 17, 71. 1-
Deazariboflavin retains the ability to undergo both types of electron transfer 
processes, as the central pyrazine ring remains intact. However, replacement of the 
N1 with carbon of the isoalloxazine ring decreases the redox potential of this analog 
from -208 mV to -280 mV 18. Substitution of the N5 with a carbon converts the 
central pyrazine ring into a pyridine ring, rendering this analog incapable of 












Figure 2.1 Structure of 1-deaza and 5-deazariboflavin. 
 
The role of the flavin N10 ribityl side chain hydroxyls  has been studied through 
the use of deoxyflavins, such as 2-deoxyflavin, in a number of flavoenzymes such as 
monoamine oxidases A and B 72, electron-transfer flavoprotein 13 and  medium chain 
acyl-CoA dehydrogenase (MCAD) 28.  The deoxyflavins lack the ribityl OH group 
and provide a convenient method for identifying the significance of hydrogen bonds 
to this portion of flavin. In particular, mechanistic studies of MCAD with 2-
deoxyFAD strongly suggest that an observed hydrogen bond between the 2ʹ-OH of 
FAD to the thioester carbonyl of CoA is important for substrate orientation and 
activation during dehydrogenation 28. An analogous role has been proposed for IYD.  
Co-crystal of mIYD and MIT show a hydrogen bond between the 2ʹ-OH of the FMN 
ribityl chain and phenolic OH of iodotyrosine 63. Active site interactions between 
FMN and the protein are minimal when compared to those between the cofactor and 
MIT. Therefore all cofactor-substrate interactions, including the hydrogen bond to the 




Scheme 2.1 Proposed 1e- mechanism for the reductive dehalogenation of MIT by 
IYD. 
 
The currently proposed mechanism for the reductive dehalogenation of MIT 
catalyzed by IYD, involves the formation and stabilization of a non-aromatic keto 
tautomer before direct electron transfer from FMN to the substrate and expulsion of 
iodide (Scheme 2.1)46. The 2ʹ-OH of the FMN has been suggested to act as a general 
acid/base, promoting tautomerization of MIT to an electron deficient species. To test 
this hypothesis, mechanistic studies of IYD reconstituted with 2-deoxyFMN were 
pursued. The goal of this chapter was to reproduce the chemical synthesis of 2-
deoxyriboflavin as described by Massey 23 and enzymatically phosphorylate this 


















2.2 Results and Discussion 
2.2.1 Synthesis of 2-Deoxyriboflavin 
Ribitylation of 3,4-Dimethylaniline  
Preparation of 2-deoxyriboflavin started with ribitylation of the commercially 
available 3,4-dimethylaniline with 2-deoxyriboflavin (Scheme 2.2) . The synthetic 
route described by Massey utilized the Tishler-condensation method for flavin 
synthesis 73. Isolation and crystallization of the Schiff base 2.1 formed from the 
condensation of 2-deoxyribose and the dimethylaniline produced the expected imine 
in 59% yield. However, subsequent reduction in the presence sodium borohydride 
gave only 30% of the desired ribitylated aniline 2.2. The starting material could not 
be recovered. Another published method made use of a one pot reductive amination 
of the dimethylaniline and D-ribose in the presence of sodium cyanoborohydride to 
form a similar ribitylated aniline 74. Following this method the yield of 2.2 was 
approximately doubled to 62%. Increase in yields which resulted from changing 
procedures can be attributed to the milder reductant and the immediate reduction of 
the imine upon formation in the one-pot reaction, driving the reaction equilibrium to 
the right. 1H NMR spectra showed chemical shifts corresponding to the aromatic ring 
(δ 6.86 (1H); 6.50 (1H); 6.43 (1H) ppm) and ribityl chain (δ 3.73 - 3.12 (6); 1.99 (1H) 
and 1.74 (1H) ppm) of the ribitylated product (Appendix A.1). ESI-MS confirmed 
formation of 2.2 showing a mass at 240.1 m/z (Appendix A.2). These data were in 







Scheme 2.2 Initial A) and modified B) synthetic schemes for the formation of 2-
deoxyribityl- 3,4- dimethylaniline (2.2). 
 
 
Diazotization of 2-Deoxyribitylated-3,4-Dimethylaniline 
Diazotization of 2.2 with freshly prepared benzene diazonium chloride 
resulted in formation of a dark red oil (Scheme 2.3)23. 1H NMR analysis of this 
product showed a very complex aromatic region (Appendix A.3). Signals at δ7.88 
(d), 7.86 (d), 7.52 (t), 6.67 (d) ppm correspond to the expected signals of the diaza 
substituted aromatic ring of 2.3. Some additional signals at δ7.06 (t) and 6.55 (t) ppm 
may correspond to aniline, suggesting either a mixture of starting materials and 
product or decomposition.  ESI –MS spectra showed the mass of the diazotization 
product 2.3 at 344.2645 m/z (theoretical m/z = 344.1929), and masses corresponding 
to aniline and its two derivatives used in the reaction (aniline at 94.0 m/z; 3,4-
dimethylaniline at 122.1 m/z and 2-deoxyribitylated-3,4-dimethylaniline at 240.1 
m/z). Carrying crude 2.3 onto the final condensation step without further purification 




Scheme 2.3 Diazotization of 2-deoxyribitylated-3,4-dimethylaniline (2.2). 
 
TLC monitoring of the diazotization reaction in ethyl acetate showed 4 spots 
with relatively good separation. The crude product was purified on silica using ethyl 
acetate, followed by elution with chloroform and methanol gave 7 fractions. 1H NMR 
analysis of these fractions showed them to contain four different mixtures, confirming 
separation of the crude reaction mixture. The 1H NMR spectrum of one fraction in 
particular (Fraction 4) showed signals corresponding to the aromatic ring (δ 7.88 - 
6.77 ppm) and ribityl chain (δ4.80 - 3.50 ppm)  (Appendix A.4) of the expected 
diazotization product 2.3 as estimated by a 1H NMR prediction (ChemDraw Ultra 
7.0).  MS-ESI of this fraction (Appendix A.5) was also comparable tocomputational 
estimates (ChemDraw Ultra 7.0) for 2.3.  
Formation of 2-Deoxyriboflavin 
The final step towards the synthesis of 2-deoxyriboflavin (Scheme 2.4) was 
the acid-catalyzed condensation of barbituric acid to the diazo-aniline 2.3 to yield the 




degradation back to starting materials (aniline and 2-deoxyribitylated-3,4-
dimethylaniline). 2.3 and barbituric acid were suspended in n-butanol and heated to 
reflux in the presence of glacial acetic acid. This conversion was monitored using a 
dual TLC solvent system to enable observation of both starting material consumption 
and product formation. Since the diazo starting material 2.3 was soluble in ethyl 
acetate and the expected product, due to its higher polarity, was more soluble in a 
mixture of 30% methanol in chloroform, the reaction was monitored via TLC using 
either of these solvents as the eluent.   In addition, the product displays a yellow 
fluorescence under UV light, whereas the starting material does not.  After 4 hours, 
TLC of the reaction mixture using ethyl acetate as the eluent showed a decrease in 
starting material and a yellow fluorescent spot at the baseline.  TLC using 30% 
methanol in chloroform as the eluent showed a yellow fluorescent spot mid-way up 
the plate, indicative of product formation according to the literature 23.  The reaction 
was continued overnight to ensure full consumption of starting material.  A TLC 
taken the next day showed no difference to that taken at 4 hours and it was assumed 
that the reaction had reach completion after 4 hours. The reaction was then stopped, 
cooled to room temperature and n-butanol was removed to give a reddish orange 
solid.  The crude solid was purified on HPLC initially using an isocratic system of 
85% 10 mM ammonium formate buffer and 15% methanol. Two peaks were 
observed with the expected UV signal around 445 nm and 370 nm for 2-
deoxyriboflavin (tr =16 and 19 minutes respectively).  However due to the strong 
tailing observed (Figure 2.3), the method was optimizes for better separation to a 




in an improved separation of 2-deoxyriboflavin from the crude material (Figure 2.3), 
this procedure prove to be irreproducible as a buildup of air bubbles was created in 
the organic pumps from methanol overtime. To overcome this issue, the organic 
solvent was changed to acetonitrile and the HPLC method was again modified, this 
time to a linear gradient of 0.1% trifluoroacetic acid in water to 50% acetonitrile over 
30 minutes described by Kiessling 74. These conditions were reproducible and gave 
the best separation of the final product from the crude mixture (Figure 2.4).  1H NMR 
analysis (Appendix A.6 ) of the material collected at 15 minutes showed chemical 
shifts for the aromatic ring (δ 7.98 and δ 7.90 ppm)  and ribose chain (δ 3.76 - δ 3.47 
ppm), consisted with the predicted spectrum(ChemDraw Ultra7.0) and were 
comparable to 1H NMR of 2-deoxyriboflavin taken in DMSO 75.   ESI-MS observed 
[M+] for the synthesis 2-deoxyriboflavin (Appendix A.7) agreed with the literature 
value of 361.1 m/z 23. 






Efforts made to scale up the production of 2-deoxyriboflavin for 
phosphorylation, revealed the limitations of using preparative HPLC for purification. 
Low solubility of the crude product mixture in 0.1% TFA in water resulted in product 
loss during sample filtration as well as increased pressure during HPLC runs. These 
issues inspired the use of a Waters Sep-Pak® Plus C18 cartridge for large scale 
purification. The Sep-Pak proved to be a suitable alternative to preparative HPLC 
(Figure 2.5). Since the crude reaction mixture did not have to be filtered before 
purification, product that had previously been discard due to low solubility in the 
aqueous buffer could now be purified as this material became more soluble when 




Figure 2.3 HPLC chromatographs of the 2-deoxyriboflavin purification 
using A) an isocratic system of 15% methanol in 10 mM ammonium formate  pH 
6.02 and B) a linear gradient system of 27% methanol in 10 mM ammonium formate  


























Figure 2.4 HPLC chromatograph of 2-Deoxyriboflavin purification using riboflavin 
as a standard. Product purification was monitored at 450 nm using a 30 min linear 
















Figure 2.5 Comparison of 2-deoxyriboflavin final purification using HPLC and 
Waters Sep-Pak®. Product purification was monitored at 450 nm using a 30 min 





2.2.2 Enzymatic Phosphorylation of 2-Deoxyriboflavin using Riboflavin 
Kinase 
Phosphorylation of riboflavin following both chemical and enzymatic methods 
has been described in the literature 70.  There are two traditional methods for the 
enzymatic formation of FMN from riboflavin. The first utilizes flavokinase 
(ATP:riboflavin-5′-phosphotransferase, EC 2.7.1.26)  to directly transfer a phosphoryl 
group from ATP to the 5′ hydroxyl group of riboflavin. The second requires the 
phosphodiester cleavage of FAD formed from the flavokinase-FAD synthetase 
complex historical isolated from Brevibacterium ammoniagenes 18. Conversion of 
FAD to FMN is then achieved by phosphodiester cleavage using Naja Naja snake 
venom 18.The second method is most commonly used, due the lower substrate fidelity 
of FAD synthetase from B. ammoniagenes compared to flavokinase 18.  Since the co-
factor of IYD is FMN, with hopes of avoiding the additional cleavage step, we 
decided to follow the former method using flavokinase. The human riboflavin kinase 
(RFK) plasmid was provided by Dr. Zhang from UT-Southwestern, whose lab solved 
the crystal structure in 2003 76. RFK was expressed and purified as described via a 


































Figure 2.6 Denaturing SDS-page gel of hsRFK Ni2+affinity purification. 
 
Although the Zhang papers provided detailed protocols for the expression and 
purification of RFK 76, 77, no procedures were listed for the conversion of riboflavin to 
FMN. Again many protocols for this phosphorylation reaction are present in the 
literature however, the method describe by Mack 78 was chosen due to its simplicity. 
The reported HPLC analysis conditions used 100 mM ammonium formate (pH 3.7) 
and methanol. However, due to the introduction of air bubbles into HPLC pump as 
discovered during the initial use of methanol for purification of 2-deoxyriboflavin, the 
organic solvent was changed to acetonitrile. Using the modified conditions of a 25 
minute linear gradient from 0% to 55% acetonitrile over 25 with 100 mM ammonium 
formate (pH 3.7) as the aqueous buffer,  HPLC chromatographs of the assay (Figure 
2.7) showed that after 24 hours approximately 60% of the riboflavin (tr = 15 min) was 





















Figure 2.7 HPLC chromatograph of riboflavin kinase (RFK) phosphorylation of 
riboflavin to FMN. Product formation was monitored at 450 nm using a 25 min linear 
gradient from 0% to 55% acetonitrile with 100 mM ammonium formate (pH 3.7) as 
the aqueous buffer.  
 
While these conditions worked well for the separation of riboflavin from 
FMN, the previously described HPLC protocol optimized for the purification of 2-
deoxyriboflavin was ultimately used to monitor 2-deoxyFMN formation.  
Additionally, the final phosphorylation conditions were modified to remove the 
reported 10 mM sodium sulfite 
78. During earlier attempts made to form the 1-
deazaFMN analog with this protocol, the presence of sodium sulfite had been 
observed to prevent phosphorylation. Optimization of the reaction conditions 
ultimately showed sodium sulfite to be unnecessary for the conversion of riboflavin to 
FMN. Due to the comparable UV-Vis absorption of the 2-deoxy analog and 
riboflavin, the phosphorylation reaction was monitored at 450 nm. After a 24 hour 
incubation at 37°C, an approximate 10% conversion of 2-deoxyriboflavin to 2-




hours resulted in full conversion to the desired FMN derivative.  Again, a Sep-Pak 
was used for final purification of 2-deoxyFMN during reaction scale up. 1H NMR and 
UPLC-MS data collected for the final product confirmed its formation based on 













Figure 2.8 HPLC chromatograph of RFK catalyzed phosphorylation of 2-
deoxyriboflavin to 2-deoxyFMN. Product formation was monitored at 450 nm using a 
30 min linear gradient from 0% to 50% acetonitrile. 
 
2.3 Summary 
2-Deoxyriboflavin was synthesized following a modified protocol utilizing a one 
pot reductive amination to yield 2-deoxyribitylated dimethylaniline. Reaction of the 
deoxyribitylated aniline with benzene diazonium chloride afforded the 2-
deoxyriboflavin precursor. Condensation of the diazo-aniline with barbituric acid in 
n-butanol, gave the final product in modest yield. Using RFK, 2-deoxyFMN was 




phosphorylation method and eliminated the need of phosphodiester cleavage as would 
be necessary with the more traditional enzymatic route of FAD synthetase. 
 
2.4 Experimental Procedures 
Materials and Methods 
All moisture and oxygen sensitive reaction were carried out in flame dried 
glassware under nitrogen atmosphere. All other reagents were obtained at the highest 
grade available and used without further purification. Water was purified to a 
resistivity of 18.2 MΩ-cm. Plasmids containing pPROEX-Hta-RFK His6 were 
provided by Dr. Hong Zhang (UT Southwestern) and transformed into Escherichia 
coli Top10 by Dr. Patrick McTamney. All protein purifications were carried out on an 
AKTA Prime FPLC (GE Healthcare Bio-sciences Corp.) unless otherwise stated. 
HisPurTM Ni-NTA resin and HisTrap HP column (1 mL) were purchased from 
ThermoScientific (Rockford, IL).  Amicon Ultra-15 centrifugal filters were purchased 
from Millipore (Billerica, MA). UV-Vis measurements were made using a Hewlett-
Packard 8453 spectrophometer. 1H NMR spectra were collected on a Bruker DRX- 
400 MHz spectrometer or Bruker AV- 400 MHz spectrometer. Chemical shifts are 
reported as δ values relative to residual solvent as an internal standard in parts per 
million (1H: CD3COCD3 δ 2.05 ppm; D2O δ 4.81; MeOD δ 4.51 ppm). Coupling 
constants (J) are reported as Hertz (Hz). Column chromatography was performed on 
Sigma-Aldrich kieselgel 60 Å silica (2-25 µM) with fluorescent indicator. High 
performance liquid chromatography (HPLC) was performed on an Econosphere C18 




acetonitrile (B) buffered with 0.1% trifluroracetic acid as the elution solvent. 
Compound elution was detected by UV at 280, 360 nm, and 450nm.  Mass 
spectrometry analysis at University of Maryland, College Park was performed on a 
JEOL AccuToF-CS ESI-MS in ESI+ ionization mode. Mass spectrometry analysis at 
The Johns Hopkins University was performed on either a Thermo Finnigan LCQ 
Deca ESI-MS in ESI+ ionization mode or on a Waters Acquity/Xevo G2 UPLC-
MS/MS in ESI+ ionization mode. 
2.1.1 Synthesis of 2-Deoxyriboflavin 23, 74 
2-Deoxyribitylated-3,4-dimethylaniline (2.2) 
3,4-Dimethylaniline (394 mg, 3.25 mmol), 2-deoxy-D-ribose (485 mg, 3.62 
mmol) and sodium cyanoborohydride (385 mg, 6.13 mmol) were dissolved in 
methanol (50 mL) and heated to 65°C for 48 hours.  Solvent was removed via rotary 
evaporation and the residue was stirred with 1 N HCl (35 mL) (to quench the excess 
sodium cyanoborohydride) until gas evolution ceased.  The solution was then 
neutralized with a saturated sodium bicarbonate solution and extracted with ethyl 
acetate (2 x 50 mL).  The combined organic layers were washed with brine, dried 
over anhydrous magnesium sulfate and filtered.  The filtrate evaporated to yield the 
desired product as a light yellow/tan solid (558 mg, 71.7 % yield). 1H NMR (400 
MHz, d4-MeOD) δ 6.90 (d, J = 8.15 Hz, 1H), 6.54 (s, 1H), 6.47 (dd, J = 2.45, 8.15 
Hz, 1H), 3.70 (dd, J = 3.84, 11.4 Hz, 1H), 3.65 (m, 1H), 3.60 (dd, J = 6.51, 4.73 Hz, 
1H), 3.49 (m, 2H), 3.20 (m, 2H), 2.16 (s, 3H), 2.11 (s, 3H), 1.98(m, 1H) 1.74 (m, 
1H). ESI+ (m/z) [M+H] for C13H21NO3 calculated: 240.1555, found: 240.1464. 




Benzene Diazonium Chloride 
Aniline (189 mg, 2.03 mmol) was dissolved in acetic acid (2 mL) and diluted 
with water (2 mL).  This solution was cooled on ice and concentrated HCl (1 mL) 
was then added drop wise.  Solid sodium nitrite (171 mg, 2.48 mmol) was then added 
to this solution slowly while maintaining a temperature below 5°C.  This mixture was 
stirred at 0°C for 10 minutes for the completion its formation.  The product was used 
without further purification.  
Diazo-2-Deoxyribitylated-3,4-Dimethylaniline (2.3) 
The ribitylated aniline 2.2 (538 mg, 2.25 mmol) obtained from the previous 
reaction (used without further purification) was suspended in a minimum amount of 
acetic acid (~2 mL), cooled on ice and stirred at 0°C for 10 minutes.  The solution 
containing benzene diazonium chloride was then added drop wise to this mixture over 
~5 minutes and stirred at 0°C for 10 min.  A concentrated solution of sodium 
hydroxide (approx. 400 mg NaOH in 1 mL water) was added with care taken to 
maintain a pH below 4 (monitored by pH paper) and the mixture was stirred at 0°C 
for 2 hours.  The reaction mixture was extracted with ether (100 mL), followed by 
two more extractions of the aqueous layer (50 mL of ether x 2).  The organic layers 
were combined, neutralized with a saturated sodium bicarbonate solution, washed 
with water and dried over anhydrous magnesium sulfate.  The solvent was then 
removed via rotary evaporation to yield the crude azo product as a red oil (468 mg, 
60.6% yield).  Chromatography purification on silica using ethyl acetate as the 
eluatant resulted in the desired product as a red solid. 1H NMR (400 MHz, d6-




(d, J = 6.75 Hz, 1H) 6.77( s, 1H), 4.06 (d, J = 6.98 Hz, 1H), 3.85 (m, 1H) 3.75 (m, 
1H) 3.67 (m, 1H), 3.56 (m, 1H), 3.52 (m, 2H), 2.32 (s, 3H) 2.26 (s, 3H), 1.85 (m, 
2H). ESI+ (m/z) [M+H] for C19H25N3O3 calculated: 344.1929, found: 344.2645. 
Values agree with computational estimates (ChemDraw Ultra 7.0). 
2-Deoxyriboflavin 
 Purified diazotizated material 2.3 (468 mg, 1.36 mmol) and barbituric acid 
(180 mg, 1.40 mmol) were suspended in n-butyl alcohol (10 mL).  Acetic acid (2.5 
mL) was then added and the mixture heated to reflux and allowed to stir overnight.  
TLC of the reaction mixture at this time using ethyl acetate as the elutant showed a 
yellow fluorescent spot at the base line. In comparison a TLC of the reaction mixture 
using 30% methanol in chloroform as the eluatant showed the yellow fluorescent spot 
closer to solvent head.  n-Butanol was then removed via rotary evaporation to give 
the crude material as a reddish orange solid (438 mg).  This solid was purified by 
HPLC (100% →50% A:B; 0.1% Trifluoroacetic acid in water: Acetonitrile, retention 
time approx. 15 min) to yield a yellow solid (34 mg, 70 % yield). 1H NMR (400 MHz, 
d4-MeOD): δ 7.98 (s, 1H), 7.90 (s, 1H), 3.62-3.55 (m, 6H), 2.60 (s, 3H), 2.48 (s, 3H), 
2.28 (m, 1H), 1.98 (m, 1H). Values agree with computational estimates (ChemDraw 
Ultra 7.0) and were comparable to literature 75. ESI+ (m/z) [M+H] for C17H20N4O5 
calculated: 361.1467, found: 361.1508. Value agreed with literature 23.  
2-DeoxyFMN  
200 μM 2-deoxyriboflavin, 10 mM MgCl2, and 4mM ATP were combined in 
potassium phosphate buffer pH 7.4 (total reaction volume, 1mL) and pre-incubated at 




reaction was incubated at 37°C for 24-48 hours to allow for full conversion of 2-
deoxyriboflavin to 2-deoxyFMN before HPLC purification using the condition 
described above to yield a yellow solid. 1H NMR (400 MHz, D2O): δ 7.57 (s, 1H), 
7.55 (s, 1H), 3.85 (m, 1H), 3.75 (m, 1H), 3.60 (m, 1H), 3.52 (m, 1H), 2.36 (s, 3H), 
2.24 (s, 3H), 2.04 (m, 2H), 1.78 (m, 1H). ESI+ (m/z) [M+H] for C17H20N4O5 
calculated: 441.1131, found: 441.1166. 
Protein Expression and Purification of hsRFK  
Clones containing pPROEX-Hta-RFK His6 were grown in LB media contain 
ampicillin (100 μg/ml) at 37°C to an OD600 between 0.6 and 0.8. The medium was 
then cooled to 18°C and cells were induced via incubation with 0.4 mM ITPG at 
18°C with shaking for 4 hours. Cells were then harvested by centrifugation at 5,000 x 
g for 6 mins (4°C) and the cell pellet was resuspended for affinity purification (500 
mM sodium chloride, 50 mM sodium phosphate pH 8). 
Cells were lysed via 4 passages through a French press at approximately 10,000 
psi. Lysates were centrifuged with 150 µM FMN at 40,000 x g for 1.5 hr (4°C) to 
remove cellular debris. Supernatant was filtered (0.22 µm PES) to remove any 
additional particulate matter before being loaded onto a HisTrap HP column (1 mL) 
chelated with Ni2+ using an AKTA Prime FPLC. Soluble lysates were applied to the 
affinity column, washed with 5 column volumes of wash buffer (500 mM sodium 
chloride, 50 mM sodium phosphate pH 8.0, 20 mM imidazole) and eluted using a 
linear gradient of 20-250 mM imidazole in the wash buffer (20 mL). Fractions 
containing RFK-His6, as identified by SDS-PAGE, were pooled and dialyzed against 




the final purified hsRFK-His6 were determined using an ε280 of 21,430
-1 cm -1. The 
concentration of bound FMN cofactor was determined using an ε450 12,500 M




Chapter 3: Preparation and Reconstitution of IYD 
3.1 Introduction 
The association and dissociation of flavoproteins into apoprotein and the flavin 
cofactor is a well-accepted phenomenon 70.  This reversible relationship has been 
manipulated for biochemical studies by replacement of the native cofactor with 
synthetic flavin analogs 7, 70. In order to examine the nature of the flavin ribtyl 
hydrogen bond to MIT in IYD, its FMN cofactor was removed, to generate 
apoenzyme that was then reconstituted with 2-deoxyFMN. Preliminary reconstitution 
studies were performed utilizing mIYD expressed isolated from Sf9 insect cells 79. 
Expression of IYD in this cell line while efficient was expensive and time consuming. 
Engineering of IYD fusion constructs using either thioredoxin or SUMO proteins has 
allowed for heterologous expression in E. coli 62. This method has provided a cost and 
time efficient way to obtain large quantities of soluble IYD from several organisms, 
including human for mechanistic studies  80 64. 
Mechanistic studies with 2-deoxyIYD are only possible if a method of 
reconstitution can be developed. As reconstitution requires unfolding of the native 
enzyme under harsh denaturing conditions, it is possible that the generated 
apoenzyme could be irreversible denatured, making it impossible to recovery 
enzymatic activity. Previous attempts at developing a reconstitution protocol for IYD 
were successful in generation of the apoenzyme using stepwise increases of guanidine 
hydrochloride to denature IYD 54, 79. However, the reincorporation of FMN did not 




IYD is critical for an accurate measurement of its enzymatic activity.  Therefore, 
optimizations of the IYD reconstitution protocol were made using the enzyme’s 
native cofactor FMN. This served as a positive control and would be used to 
differentiate whether observed changes were due to formation of the apoenzyme and 
its reconstitution or cofactor modification. Discussed in this chapter is the 
development of an IYD reconstitution protocol and its use to generate both FMN and 
2-DeoxyFMN reconstituted hIYD. Substrate dissociation constants (KD) as well as 
Michaelis-Menten kinetic were determined for each reconstituted enzyme. These 
values were then compared to native hIYD to measure the effects of reconstitution on 
catalytic ability.  
 
3.2 Results and Discussion 
3.2.1 Reconstitution of hIYD with FMN and 2-DeoxyFMN 
 
Apo-hIYD was initially generated as described in a modified protocol 
utilizing stepwise increases of guanidine hydrochloride to denature hIYD 54. This 
method resulted in the release the non-covalently bound FMN and loss of hIYD’s 
characteristic yellow color. UV-Vis measurements taken of the freshly formed 
apoenzyme showed no absorbance at 450 nm. A discontinuous D125IT activity assay 
81 of apo-hIYD showed the expected loss of deiodinase activity (Figure 3.1). 
Incubation of apo-hIYD with 2 equivalents of FMN follow by an overnight dialysis in 
the standard hIYD purification buffer containing 500 mM NaCl should have 
produced the reconstituted haloenzyme, marked by the return of deiodinase activity. 






deiodinase activity assay of this prepared enzyme were comparable to that of 




















Figure 3.1 DIT deiodinase activity of native, apo and FMN reconstituted hIYD under 
500 mM NaCl conditions. The activity of hIYD (0.08 μM) with DIT was determined 
using the standard discontinuous D
125
IT iodide release assay.  
 
 
Concerns over irreversible denaturation of hIYD led to a literature search for 
flavoenzyme reconstitution methods.  One article 70 highlighted the effects of buffer 
conditions on generation and reconstitution of apoflavoprotein.  High salt 
concentrations, while generally useful for apoenzyme stability, can create an 
environment that inhibits the uptake of flavin due to electrostatic repulsion 70. The 
dialysis buffer initially used for reconstitution contained the standard 500 mM NaCl 
used for preparation of hIYD. During the preparation of hIYD for protein 
crystallography studies 64, purified hIYD was found to be stable in buffer containing 




against buffer containing 100 mM NaCl after incubation. Lowering of the salt 
concentration resulted in uptake of FMN and return of deiodinase activity. While 
these results were promising, active site occupancy was observed at only 80% for the 
reconstituted enzyme. For the native enzyme, flavin occupancy of 90% or greater is 
often observed.  Attempts were then made to increase active site occupancy to using 
40 equivalents of FMN. This also resulted in the expected return of activity, however 
a 1:1 FMN:active site ratio was never obtained. Instead occupancy was seen to be 
over 100%, indicating the presence of unbound FMN in the enzyme solution. 
Difficulty in removing of all the excess unbound FMN from solution, made it hard to 
asset how much FMN was bound to hIYD. Attempts to remove unbound FMN, 
whether by multiple buffer dialysis or spin column extractions proved to be 
ineffective. An intermediate of 5 equivalents of FMN was then settled on, as this 
amount was high enough to provide full flavin occupation, while being low enough 
that any unbound flavin could be removed from solution via overnight dialysis. Under 
these conditions, FMN was removed and replaced in hIYD resulting in the loss and 
recovery of deiodinase activity as expected (Figure 3.2). Michaelis-Menten kinetic 
constants obtained for the reconstituted holoenzyme were within an order of 



















Figure 3.2 DIT deiodinase activity of native, apo and holo-hIYD reconstituted with 5 
eq of FMN. The activity of hIYD (0.08 μM) was determined using the standard 
D
125
IT iodide release assay. Assays were performed in triplicate and the average data 
sets were fit to Michaelis-Menten kinetics using Origin 7.0. Error bars represent 
standard deviation at each concentration. 
 
 
Table 3.1 Kinetic parameters of hIYD. 




 These results, while encouraging, ultimately proved to be irreproducible, as 
successive preparation of FMN reconstituted hIYD yielded large variability in 
observable deiodinase activity (30 to 100% recovery) due to active site occupancy  
(60 - 100%) . Attempts to increase active site flavin occupancy drove the decision to 
double the quantity of FMN used during the apoenzyme incubation step from 5 to 10 
equivalents of FMN. However the increased cofactor concentration had no effect on 
hIYD KM (μM) Vmax (μM/hr) kcat (1/s) 
Native 28 ± 7.5 137 ± 14 0.48 ± 0.06 
Apo 0.02 0.30 <0.002 




the recovery of deiodinase activity (Figure 3.3). Problems seen in reproducibly of 
active site occupancy indicated decrease flavin uptake may be due to the decreased 
stability of the generated apoenzyme caused by irreversible damage during 
denaturing. Therefore, a means of stabilizing the apoprotein long enough to 











Figure 3.3 D125IT deiodinase activity of native, apo and holo-hIYD reconstituted 
with 5 and 10 equivalents of FMN.Activity was determined using the standard D
125
IT 
iodide release assay. 
 
Efforts made to find a method that would effectively generate and stabilize the 
apoenzyme without inhibiting flavin uptake lead to a second review of the literature.  
A number of methods discussing the use of affinity chromatography to aid in 
apoenzyme stabilization were consulted 82, 83 as affinity chromatography was used for 
generation of apo-hIYD. One affinity column protocol utilized immobilized metal 
affinity chromatography (IMAC) for both apoenzyme generation and reconstitution 
of the FAD-containing PAS domain of NifL 83. The main difference between this 




affinity column but instead reconstituted on-column by washing with a 10 mM flavin 
solution using a cyclic loop. The potential benefits of this method include: 1) 
increased apoenzyme stabilization during flavin uptake as the His tag helps the 
enzyme to correctly refold , 2) the ability to visualize flavin uptake before elution due 
to the large extinction coefficient of flavin and 3) recycling of the flavin containing 
solution. Recycling of the flavin solution made this method particularly attractive as 
limited supplies of 2-deoxyFMN were available for reconstitution.   
To test the effectiveness of this new protocol 83 for hIYD, apo-hIYD was 
generated on an affinity column by stepwise washes with GdnHCl (0-1.5 M). The 
bound apo-hIYD was then washed with buffer containing 1 mM FMN and 100 mM 
NaCl. After 2 hours of recycling the FMN solution over the column bound enzyme, 
the column was washed with a flavin free buffer to remove any excess flavin that had 
not bound to the protein. At the end of that time a well-defined yellow band could be 
seen on the column, indicating flavin uptake and the generation of the reconstituted 
hIYD. Deiodinase activity of the initial on-column reconstituted hIYD was less than 
20 % of native hIYD. While these results showed hIYD could be reconstituted using 
the on-column method, optimization was needed to improve the recovery of 
enzymatic activity.  Furthermore, since synthesis of the 2-deoxyFMN analog 
provided milligram amounts of the desired product, millimolar flavin concentrations 
would not ideal for its incorporation into hIYD. A modified on-column procedure 
using buffer containing 10 fold less FMN was then attempted to see how enzyme 
activity would compare. To compensate for the decrease in flavin concentration the 




uptake. This resulted in an improved recovery of enzymatic activity compared to the 
initial 1 mM FMN reconstitution. The 100 μM FMN reconstituted enzyme had 
regained approximately 70% of the native deiodinase activity (Figure 3.4).  












Figure 3.4 D125IT deiodinase activity of native, apo and holo-hIYD reconstituted on 
Ni2+ affinity column using100 μM FMN. Activity of hIYD (0.08 μM) was determined 
using the standard D
125
IT iodide release assay. Assays were performed at least twice. 
Error bars represent standard deviation at each concentration. 
 
 
Initial attempts at the formation of 2-deoxyFMN reconstituted hIYD with the 
newly modified on-column method produced a reconstituted enzyme that was stable 
for several hours, but begin to precipitate after 24 hours. Short lived stability of 2-
deoxyhIYD suggested that while hIYD was indeed able to recombine with 
2deoxyFMN, enzyme aggregation, possible due to the presence of irreversible 
damage enzyme, was causing precipitation. To remedy this problem on-column 
reconstitution of the membrane truncated hIYD fusion protein (SUMO-hIYD(Δtm)) 




in the refolding process of the apoenzyme. Also, the use of gel filtration 
chromatography to purify the reconstituted hIYD would remove excess FMN as well 
as any remnants of damaged apoenzyme from the denaturation step. To date this 
method has produced the best result, as FMN reconstitution enzyme with 95-100% 
flavin occupancy and the return of native level deiodinase activity (Figure 3.5). In 
addition, the stability of reconstitution hIYD was comparable to that of purified 
native hIYD. 2-DeoxyhIYD generated following the same method was now stable 











Figure 3.5 DIT deiodinase activity of native, apo and holo-hIYD reconstituted on 
Ni2+ affinity column using 100 μM FMN.The activity of hIYD (0.08 μM) was 
determined using the standard D
125
IT iodide release assay. Assays were performed in 
triplicate. The averaged data was fit to Michaelis-Menten kinetics using Origin 7.0. 
Error bars represent standard deviation at each concentration. 
 
 
3.2.2 Equilibrium binding of MIT and DIT to 2-deoxyhIYD 
Characterization of 2-deoxyhIYD began with measurement of substrate 




site flavin fluorescence upon ligand association. This data was compared to similar 
affinity measurements of MIT to FMN reconstituted hIYD (Figure 3. 6). Removal of 
the 2ʹOH significantly decreased affinity of the enzyme for substrate >4,000 fold 
compared to both wildtype and FMN reconstituted hIYD (Table 3.2). Measurements 
of DIT binding to 2-deoxyhIYD (Appendix B.1) also showed a drastic >3,000 fold 
decrease in substrate affinity (Table 3.2). This suggests the hydrogen bond between 
substrate and the ribtyl 2ʹOH is necessary for efficient substrate binding. Decreased 
affinity for DIT when compared to MIT was expected for 2-deoxyhIYD due to the 
steric bulk of DIT. 2-deoxyhIYD was observed to bind DIT 5 fold less tightly than 
MIT. This difference is doubled for native hIYD which binds DIT 10 fold less tightly 
than MIT. A possible reason for this observation is that removal of the 2ʹOH allows 
for better active site accommodation of bulkier DIT.   
 
 








Dissociation constants were calculated by nonlinear fit of data to Equation 3.1 (See 
Figure 3.6 and Appendix B).  










 KD (μM) 
hIYD MIT DIT 
Native*  0.15 ± 0.04 1.5 ± 0.15 
FMN Reconstituted  0.42 ± 0.13 - 





















Figure 3.6  Equilibrium binding of MIT to FMN reconstituted hIYD and 2-
deoxyhIYD. Binding was monitored by the change in fluorescence of flavin bound to 
enzyme (4.5 μM) in solution of 100 mM postassium phosphate and 200 mM 
postassium chloride (pH 7.4) at 25°C using λex of 450 nm and λem of 527 nm. The 
average of three independent measurements were normalized and plotted against MIT 
concentrations. Error bars represents the standard deviation of three measurements. 
 
 
3.2.2 Deiodinase Activity of FMN and 2-DeoxyFMN Reconstituted 
hIYD 
Michaelis-Menten kinetic constants for the FMN reconstituted hIYD were 
determined by the previously mentioned discontinuous D125IT assay (Figure 3.5). It 
was found that removal and replacement of the native FMN cofactor had no 
significant effects on the catalytic ability of hIYD towards native substrate (Table 
3.3). The calculated kcat/Km of 0.74 ± 0.08 min
-1 µM-1 was close to that of native 
hIYD (0.54 ± 0.01 min-1 µM-1) and falls within the range of 0.28 min-1 µM-1 to 3.5 
min-1 µM-1 detected for a series of IYD obtained from highly diverse organisms 80. 
This indicates that the process of reconstitution itself is not detrimental to the 





Table 3.3 Kinetic parameters of native, FMN reconstituted and 2-deoxyhIYD with 
DIT. 
Kinetics constants were calculated by fit to Michaelis-Menten kinetics.  
*Values for native hIYD were obtained from 84. 
 
To determine the effects of 2-deoxyFMN on the catalytic activity of IYD, protein 
dependence of MIT turnover was monitored by HPLC (Figure 3.6). Varying 
concentration of 2-deoxyhIYD (0.4, 2.5 and 4.5 μM) were reduced by sodium 
dithionite in the presence of 1 mM MIT.  HPLC analysis of each reaction revealed the 
formation of tyrosine at each enzyme concentration A reaction time course was obtain 
for MIT deiodination by 0.4 μM 2-deoxyhIYD (Appendix B.2). Michaelis-Menten 
kinetic constants obtained for 2-deoxyhIYD (kcat/Km of 0.06 ± 0.04 min
-1 µM-1) 
showed an approximately 10 fold decrease in catalytic efficiency when compared to 
native hIYD (kcat/Km of  0.60 ± 0.02 min
-1 µM-1) (Figure 3.7). Similarly, numbers 
were obtained using the standard D125IT assay (Table 3.3, Appendix B.3). These 
results were surprising. Considering the large decrease in substrate binding affinity, 
2-deoxyhIYD was expected to be unable to support catalysis. The hydrogen bond 
between FMN and substrate was thought to be necessary for substrate orientation, 
possible acting as an anchor to help position substrate over the isoxallozine ring 64. 
Moreover, the ribityl 2ʹOH had been hypothesis to be important for substrate 
 
MIT DIT 








Native* 12 ± 2.5 7.3 ± 1.0 0.60 ± 0.02 73 ± 3.7 15.2 ± 0.7 0.54 ± 0.01 
FMN 
Reconstituted 
__ __ __ 22.5 ± 3.3 16.7 ± 1.0 0.74 ± 0.08 




activation, through stabilization of a substrate intermediate during turnover, as will be 
discussed further in Chapter 4. 
Figure 3.6 Representative HPLC chromatographs of the deiodination of MIT by 2-
deoxyhIYD. Deiodination was monitored in the absence (A) and presence (B) of 0.4 
μM 2-deoxyhIYD. Product purification using a 45 min linear gradient from 100% 















Figure 3.7 MIT deiodinase activity of 2-deoxyhIYD. 
The activity of 2-deoxyhIYD (0.4 μM) was determined using a HPLC assay.  Assays 
were performed in triplicate. The averaged data was fit to Michaelis-Menten kinetics 





Reliable reconstitution of hIYD requires removal of the native FMN in a manner 
that denatures the native protein without causing irreversible damage.  Immobilized 
metal affinity chromatography (IMAC) provides added stabilization to apohIYD 
during enzyme refolding and flavin replacement. Low salt concentrations of 100 mM 
are crucial during hIYD reconstitution, as increased ionic strength inhibits flavin 
uptake by apo-hIYD. Gel filtration chromatography provides efficient purification of 
reconstituted hIYD from irreversibly denatured enzyme, generating a stable FMN 
haloenzyme with deiodinase activity comparable to native IYD. Removal of the FMN 
ribityl 2’OH in hIYD decreases substrate affinity greater than >3,000 fold, however 
does not significantly alter catalytic activity.  This data suggest that the hydrogen 




Na125I used for radiolabeling of DIT was obtained from Perkin Elmer (Waltham, 
MA).  All other reagents were obtained at the highest grade available and used 
without further purification. Amicon Ultra-15 centrifugal filters were purchased from 
Millipore (Billerica, MA). HisTrap HP column (1 mL and 5 mL) and Sephacryl TM S-
200 resin were purchased from GE Healthcare Life Sciences. The pET28-SUMO-JH1 
plasmid was prepared by Dr. Jimin Hu 64. Plasmids containing pET-SUMO-
hIYD(Δtm)His6 were transformed into Escherichia coli Rosetta2 (DE3). All protein 




Corp.) unless otherwise stated. UV-Vis measurements were made using a Hewlett-
Packard 8453 spectrophometer. Fluorescence intensities were measured with a 
HORIBA Scientific FluoroMax fluorescence spectrophotometer. High performance 
liquid chromatography (HPLC) was performed on a Varian Microsorb-MV 300 (250 
x 4.6 mm) C18 reverse-phase column using 10 mM TEAA buffer pH 5.5 (A) and 
acetonitrile (B) as the elution solvent. Compound elution was detected by UV at 274 
nm and 280 nm. 
3.4.1 Protein Expression and Purification of hIYD 
E. coli transformed with pET-SUMO-hIYD(Δtm)His6 was grown in LB media 
with chloramphenicol (34 μg/mL) and kanamycin (50 μg/mL) at 37°C to an OD600 
between 0.6 and 0.8. The medium was then cooled to 16°C and induced via shaking 
incubation with 20 μM isopropyl-β-D-thiogalactopyranoside (IPTG) for 18 hours. 
Cells were then harvested by centrifugation (5,000 x g for 5 min (4°C)) and 
resuspended for affinity purification in buffer containing 500 mM sodium chloride, 
50 mM sodium phosphate pH 8.0, 0.01 mM dithiothreitol, and 10% glycerol. Cells 
were then flash frozen and stored at –80 ºC until use. 
Cells were lysed via 4 passages through a EmulsiFlex C-3homogenizer (Avestin) 
at approximately 15000 psi in affinity purification buffer supplemented with 180 µM 
FMN.  Lysates were centrifuged at 40,000 x g for 3 hour at 4°C to remove cellular 
debris. Supernatants were then filtered (0.22 µm PES) to remove additional 
particulate matter before affinity purification. Soluble lysates were loaded on a 1 mL 
HisTrap TM HP column chelated with Ni2+, washed with 6 column volumes of wash 




dithiothreitol, 10% glycerol, 20 mM imidazole) and eluted using stepwise increases in 
imidazole (6 column volumes of 20 mM, 6 column volumes of 70 mM, 2 column 
volumes of 100 mM, and finally 3 column volumes 250 mM imidazole). Fractions 
containing SUMO-hIYD(Δtm)His6  as identified by SDS-PAGE, were pooled and 
incubated with approximately 1:100 ratio of Ulp1 protease per mg of fusion protein 
for 12 h at 4°C.  Digested SUMO-hIYD(Δtm)His6  was concentrated to 1 mL using an 
Amicon Ultra-15 centrifugal concentrator (MWCO = 10 KDa) before being loaded 
onto Sephacryl TM S-200 resin for gel filtration purification using buffer 
containing100 mM sodium chloride, 50 mM sodium phosphate pH 7.4, 1 mM 
dithiothreitol, and 10% glycerol. Concentrations of the final purified hIYD(Δtm)His6 
was determined using an ε280 of 38,000 M
-1 cm-1. The concentration of bound FMN 
cofactor was determined using an ε450 12,500 M
-1 cm-1.  
 
3.4.2 Generation of apo-hIYD 
Purified hIYD(Δtm)His6 was loaded on a 1 mL HisTrap
 TM HP column chelated 
with Ni2+. Using an AKTA Prime FPLC, the protein was washed with 10 column 
volumes of native wash buffer (50 mM sodium phosphate pH 7.4, 500 mM sodium 
chloride, 0.1 mM dithiothreitol, 10% glycerol and 20 mM imidazole) before being 
washed by a stepwise gradient of native wash buffer supplemented with 1.5 M 
guanidine hydrochloride (GdnHCl). The stepwise gradient consisted of sequential 10 
columns volumes washes with 0.0 M, 0.6 M and 1.05 M GdnHCl respectively, 
followed by one 20 column volume wash with 1.5 M GdnHCl. The protein was then 
refolded on the column by sequential 10 columns volume washes with 1.05 M, 0.6 M 




3.4.3 Reconstitution of apo-hIYD 
Using an AKTA Prime FPLC soluble lysates of SUMO-hIYD(Δtm)His6 were 
loaded onto a 5 mL HisTrap TM HP column chelated with Ni2+ and washed with 6 
column volumes of native wash buffer (NWB)  (500 mM sodium chloride, 50 mM 
sodium phosphate pH 7.9, 0.01 mM dithiothreitol, 10% glycerol, 20 mM imidazole) 
followed by stepwise increases in imidazole to remove extracellular debris (6 column 
volumes of 70 mM imidazole in NWB , 2 column volumes of 100 mM imidazole in 
NWB).  Apo-SUMO-hIYD(Δtm)His6 was then generated using a stepwise gradient of 
native wash buffer containing 1.5 M GdnHCl as described above. Column bound apo-
SUMO-hIYD(Δtm)His6 was then washed with  reconstitution wash buffer (RWB) (50 
mM sodium phosphate pH 7.4, 100 mM sodium chloride, 0.1 mM dithiothreitol, 10% 
glycerol and 20 mM imidazole) supplemented with 200 μM of either FMN or 2-
deoxyFMN for 4 hours at 4°C at a flow rate of 1 ml/min. Reconstituted SUMO-
hIYD(Δtm)His6 was then washed with at  least 20 column volumes of flavin free 
RWB before being eluted with  250 mM imidazole in RWB. Fractions containing 
reconstituted SUMO-hIYD(Δtm)His6  as identified by SDS-PAGE, were pooled and 
incubated with approximately 1:100 ratio of Ulp1 protease per mg of fusion protein 
for 12 h at 4°C.  Digested reconstituted SUMO-hIYD(Δtm)His6  was concentrated to 
1 mL using an Amicon Ultra-15 centrifugal concentrator (MWCO = 10 KDa) and 
purified on SephacrylTM S-200 resin as described above. 
3.4.4 Fluorescence Binding 
Substrate dissociation constants were calculated based on the change in 
fluorescence of enzyme bound flavin upon titration of substrate as previously 




derivatives over a range of concentrations centered at that necessary for a 50% 
quenching of the emission signal. Fluorescence intensities were normalized by 
dividing the initial fluorescence (F0) and plotted against the ligand concentrations 
using Origin 7. Dissociation constants (KD) were obtained from the nonlinear fitting 
to the Equation 3.1 85. Reported KD values were derived from the average value of 3 
independent determinations and their error was based on the results of least squares 
fitting.  
Equation 3.1.                                     
 
F = F0 + ΔF  x     (KD + [E]0 +[S]0) –   (KD + [E]0 +[S]0)
2 - 4 [E]0[S]0  
 
                                                               2[E]0  
 
3.4.5 Deiodinase Activity 
Discontinuous D125IT Activity Assay  
Deiodination of D125IT by hIYD(Δtm) were measured by a discontinuous assay as 
previously described 81. Assay of hIYD(Δtm) and FMN reconstituted hIYD were 
typically performed by addition of a final concentration of 0.4 μM protein to 100 mM 
potassium phosphate pH 7.4, 200 mM KCl, 0.50 mM methimazole, 50 mM 2-
mercaptoethanol, D125IT (20,000 cpm) and unlabeled DIT (0-75 μM). Reactions were 
initiated by addition of sodium dithionite in sodium bicarbonate. Samples were 
incubated under ambient temperature for 1 hour and quenched by addition of 100 μL 
of 0.1% DIT (w/v) in 0.1 NaOH. A 250 μL aliquot (S) of the 1.1 mL final assay 
volume was removed and transferred to a vial containing 10% acetic acid (4.75 mL) 
in order to determine the total radioactivity for each reaction sample. The remaining 
mixture (850 μL) was then passed through a cation exchange column (3.5 mL, AG 




50W-X8 resin), washed an initial time with 10% acetic acid (4.15 mL), and the eluent 
collected (A). The column was then washed a second time with 10% acetic acid (5.00 
mL) and the eluent was again collected (B). Each sample (S, A, and B) was diluted 
with 15 mL of Fisher Scientific Scintisafe Plus 50% scintillation fluid and the amount 
of [125I]-iodide present in each sample was quantified using a Packard 1600 TR liquid 
scintillation analyzer. Assay of 2-deoxyhIYD were performed in a similar manner 
using 0 -5 mM  unlabeled DIT and quenched by addition of 100 μL of 1% DIT (w/v) 
in 0.1 NaOH. The rate of iodide release was calculated by subtracting the ratio of 
eluted 125I (F) from the background radiation (F0) as seen in equations 3.2 and 3.3, 
where t is the time (hours) after initiation and n is the moles of DIT (i.e. nmol). This 
value is multiplied by a factor of 2 because two deiodination sites exist on the DIT 
but statistically only one of the two is labeled with 125I. Values were then normalized 
for the amount of IYD (μg) added to each reaction. Kinetic constants were calculated 
by fitting the data obtained from three independent assays trials to the Michaelis-
Menten equation in Origin 7.0 kcat values were obtained from the Vmax and the 
respective molar concentration of the hIYD protein. Reported error is based on the 
results of least squares fitting. 
Equation 3.2                                   dpm A + dpm B 
                                                             850                  
                                                            dpm S 
                                                             250 
 
 
Equation 3.3                     (F1-F0) * 60min 
                                                    30 min 
 




* [DIT] * 2 = 





MIT HPLC Deiodinase Activity Assay  
Catalytic deiodination of MIT was measured by formation of tyrosine as detected 
by HPLC. Reactions were performed in buffer containing 100 mM potassium 
phosphate pH 7.4 with 200 mM KCl (1 mL total volume). MIT concentrations were 
centered around the substrate KD of 1 mM. 0.5% Sodium dithionite in sodium 
bicarbonate was used to initiate reactions. Samples were incubated under ambient 
temperature for 2 hrs and terminated via injection onto HPLC (100% →45% A:B; 
10mM TEAA pH 5.5: Acetonitrile. Product formation was monitored at 274 nm. 
Phenol (50 μM) was used as in internal standard.  Reaction rates were calculated 
using a generated standard curve for phenol/tyrosine in order to convert product area 
to nmol. The calibration curve of products (Appendix B.4) was normalized by the 
concentration of the internal standard. The response factor (RF) of product with 
internal standard was used to calculated the product formation by using Equation 3.4 
86 where Cx = concentration of analyate, Cis = concentration of internal standard, Ax = 
peak area of the analyate, A is = peak area of the internal standard.  
 
Equation 3.4                                   RF = (Ax*Cis)/(Ais*Cx) 
 
Product formation was determined by the RF and the peak area of the tyrosine 
as described above. All reactions were repeated at least twice. The average of at least 
measurements was plotted as product formation vs time by Origin 7.0. The slope of 




Chapter 4: 2-DeoxyhIYD Activity with Substrate Analogs 
4.1 Introduction 
The role of IYD in reductive dehalogenation is highly unusual for a flavoenzyme. 
Few literature examples present flavoenzyme as reductive dehalogenase. Many of 
these examples describe the necessity of flavin for enzymatic activity, but offer no 
mechanism for flavin involvement in dehalogenation 36, 87. A broader search for 
examples of reductive dehalogenation in aerobic systems yielded two well 
characterized enzymes, the bacterial TCHQ and mammalian ID 40, 41, 88. Mechanisms 
for both TCHQ and ID rely on a nucleophilic active site cysteine or selenocysteine 
residue for dehalogenation. These mechanisms however, provide no insight for IYD, 
as mutagenesis studies in mIYD have shown the removal cysteine to have no effect 
on catalysis 67. Crystal structures of mIYD further confirmed this finding as the 
enzyme’s active site was found to contain no cysteine residues 63.  
Comparison of IYD’s active site in the presence and absence of substrate has 
revealed an active site devoid of nucleophilic amino acids residues 63, 64. The presence 
of substrate induces conformational changes in IYD. These changes include the 
formation of an active site lid that sequesters the active site from solvent as well as a 
1.8 Å shift of the hydroxyl group of Thr239 (as observed in hIYD), placing this 
functionality within hydrogen bonding distance to the N5 of FMN 64. Additionally, 
MIT coordination to FMN in IYD mimics interaction typical seen between FMN and 
the protein in other flavoenzyme 63. Examples of this include but are not limited to 





As a flavoenzyme, IYD is capable of catalyzing reductive dehalogenation via 
either a 1 or 2 electron transfer process. During sodium dithionite reduction of FMN 
bound to IYD in the presence of halotyrosine, the formation of a neutral Flsq was 
detected 68. Furthermore, anaerobic titrations of hIYD conducted with the inactive 
substrate analog mono-fluorotyrosine (MFT) have detected the formation of the 
distinct Flsq with a λmax of 590 nm. Identical titrations in the absence of substrate only 
show disappearance of the characteristic FMN absorbance at λmax of 446 nm 
64. The 
previously mentioned detection of the Flsq suggests dehalogenation of MIT occurs via 
2 sequential, 1 electron transfers. 
 
 
Scheme 4.1 Proposed 1 e- mechanism for the reductive dehalogenation catalyzed by 
IYD. 
 
The mechanism of IYD’s reductive dehalogenation of MIT has been proposed to 
go through one of two 1 electron pathways (Scheme 4.1) 46. In the first pathway 
injection of a single electron from Flred directly into the phenyl ring of MIT is 
proposed to generate an aromatic anion radical intermediate. Collapse of this 




second electron from Flsq and a proton would then yield tyrosine and Flox. The second 
involves substrate tautomerization to a non-aromatic ketone. Injection of a single 
electron from Flred would result in release of iodide, forming a tyrosyl radical. The 
addition of a second electron followed by proton transfer would complete the 
catalytic cycle to give tyrosine and Flox. To date, experimental data seems to support 
the second pathway. A non-aromatic pyridine analog, used to mimic of the propose 
substrate tautomer, was found to inhibit deiodinase activity in IYD purified from 
porcine thyroid, suggesting IYD may have an affinity for a substrate tautomer 89.  
More recently, pH dependence studies were conducted with hIYD in the presence 
of DIT to examine whether a preference for the phenol or phenolate form of substrate 
exist for hIYD binding 64. The greatest affinity for substrate occurred at a neutral pH 
of 7.6 – 7.764. Any acidic or basic deviation from this pH resulted in decreased 
affinity for DIT. A plot of logKD versus pH highlighted the significance of two 
ionizable groups with estimated pKa values of ~6.6 and ~ 8.7, respectively for 
maximal binding 64.  Based on pKa values, the phenol (pKa = 6.4) and α-ammonium 
group (pKa = 7.8) of DIT have been identified as the possible the ionizable groups.  
These results are consistent with preferential binding of the phenolate form of 
halotyrosines to hIYD.   
Amongst the observed active site interaction, the phenolic group of MIT has been 
reported to share a possible a hydrogen bond with the 2ʹ-OH of the FMN ribityl chain 
and the amide backbone of Ala126 in mIYD 63. An analogous interaction between the 
2ʹ-OH of the FAD and the thioester carbonyl of acyl-CoA has been documented in 




lower the pKa of acyl-CoA, activating the substrate for dehydrogenation by MCAD 
through reconstitution studies with 2-deoxyFAD28. Likewise, another member of the 
nitro-reductase superfamily, BluB, forms a similar hydrogen bond between the 2ʹ-OH 
of the FMN and its substrate molecular oxygen 65.  
As described in Chapter 3, removal of the FMN ribityl chain 2ʹ-OH decreased the 
binding affinity of hIYD for MIT and DIT greater than 3,000 fold. However, the loss 
of this hydrogen bond between substrate and FMN was not detrimental to catalytic 
activity. 2-DeoxyhIYD was still able to deiodinate both MIT and DIT, with only a 10 
fold decreased in kcat/Km compared to wildtype hIYD. Questions about the chemical 
nature of these observations, such as effects on flavin chemistry and substrate 
activation, still remain. Discussed herein is the apparent function of the ribityl chain 
2ʹ-OH towards the reductive dehalogenation catalyzed by hIYD. 2-deoxyhIYD was 
used to probe the role of the 2ʹ-OH of FMN for cofactor redox chemistry and pKa 
requirements for substrate activation.  Binding and turnover studies were also carried 
out using an O-methyl-iodotyrosine (OMeMIT) substrate analog to block formation 
of the hypothesis of substrate tautomer. 
 
4.2 Results and Discussion 
4.2.1 The Effects of 2ʹOH on Flavin Reduction 
Redox titrations of native hIYD revealed that the presence of bound substrate 
switches the redox chemistry of FMN from a 2 electron transfer process to a 1 
electron transfer process, as observed by the accumulation of the neutral Flsq only in 
the presence of substrate 64. To verify that reinsertion of FMN had no effects on the 




hIYD as described 64. UV-Vis spectroscopy of the oxidized FMN reconstituted hIYD 
showed the characteristic absorbance max at 445 nm. Anaerobic reduction of FMN 
reconstituted hIYD using the xanthine /xanthine oxidase system rapidly decreased the 
absorbance at 445 nm, as expected (Figure 4.1A). For native hIYD, performance of 
this anaerobic reduction in the presence of excess 3-fluoro-L-tyrosine (MFT) was 
reported to yield accumulation of the neutral Flsq 
64. MFT was selected for these 
experiments because it binds tightly to the hIYD (KD =1.30 ± 0.04 μM)
84, but is not 
dehalogenated by the enzyme 68. Similarly, accumulation of the neutral Flsq was also 
observed during reduction of the FMN reconstituted enzyme with excess MFT 
(Figure 4.1B) These results again confirm that the process of reconstitution itself 









Figure 4.1 Selected spectra from the redox titration of 15 μM FMN reconstituted 
hIYD by xanthine/xanthine oxidase in the A) absence and B) presence of 0.6 mM 
MFT. Data was collected every 2 mins for over 120 mins.    
 
To investigate the effects of the FMN ribityl chain 2ʹ-OH on the redox 




the isoalloxazine ring is responsible for controlling the redox chemistry of flavin, 
removal of the 2ʹ-OH was not expected to have any effects on the reduction of FMN. 
Anaerobic reduction of oxidized 2-deoxyhIYD in the absence of substrate, resulted in 
the expected full reduction to the 2-deoxyFlhq. Similar to MIT, 2-deoxyhIYD has an 
extreme decreased affinity for MFT (KD =1.49 ± 0.07 mM, Appendix C). As a result 
an excess of 5 mM MFT was used for redox titrations of 2-deoxyhIYD.  In the 
presence of MFT, however, the 2-deoxyFlsq was never detected (Figure 4.2).  This 
result was surprising was not insular. The Flsq also went undetected during previous 
redox titrations of native hIYD with two substrate analogs, 3-iodotyramine and 4-
hydroxy-3-iodophenyl propionic acid 84. Similar to 2-deoxyhIYD’s decreased affinity 
for MIT, native hIYD shown a significant decrease in affinity for these analogs (KD = 
400 ±45 μM for 3-iodotyramine and KD = 1000 ±120 μM for and 4-hydroxy-3-
iodophenyl propionic acid), but was still able to support the turnover of both 
compounds 84. For these analogs it was suggested that the removal of their hydrogen 
bonds with the N3-O4 edge of FMN may prevent stabilization of the Flsq 
84.  This 
interaction remains intact in 2-deoxyhIYD.  However, the lack of Flsq detection for 2-
deoxyhIYD could possibly be explained by the crystal structure of IYD which show 
the 2ʹ-OH to be within 3.3Å of the N1 position, suggesting a possible hydrogen bond 
between these two groups (Figure 4.3). While is unclear how this interaction would 
affect stabilization of the neutral Flsq, hydrogen bonds between ribityl chain hydroxyl 
and the N1 position in FAD have been shown to stabilize the anionic Flsq in human 




understand if a similar relationship can be derived in hIYD, as the ionic states of the 










Figure 4.2 Selected spectra from the redox titration of 15 μM 2-deoxyhIYD in the 
presence of 5 mM MFT by xanthine/xanthine oxidase. The data was recorded every 2 









Figure 4.3 Polar contacts between the ribityl chain 2ʹ-OH and N1 of FMN in IYD. 
PDB 4TTC.    
 
4.2.2 Importance of 2ʹOH for Substrate Binding 
As described in Chapter 3, removal of the 2ʹOH was found to significantly 





a pH dependence of DIT binding 64, this decreased affinity may be attributed to 
destabilization the preferred phenolate form of the substrate from the loss of hydrogen 
bonding with the 2ʹOH. To test this hypothesis, two alternate methods were sought. 
The first involved repeating the report pH dependence of DIT binding using 2-
deoxyhIYD. It was assumed that, if the phenolate form was indeed the preferred form 
for enzyme binding, removal of the 2ʹOH would result in no difference in DIT 
binding at a lower pH. Unfortunately, due to the already observed decreased affinity 
for DIT in 2-deoxyhIYD, solution of DIT at concentrations greater than 10 mM were 
necessary to quench 50% of flavin fluorescence. At these high millimolar 
concentrations, DIT is known to have low solubility in acidic media.  Mock assays 
were conducted to test the solubility of DIT under these conditions for the planned pH 
dependence assays. A final concentration of 1 mM DIT was added to 3 mL of 100 
mM potassium phosphate 200 mM postassium chloride buffer at pH 6 and stirred at 
25°C for 2 -10 mins. While the initial addition of DIT to this solution appeared to 
dissolve, it was observed that after approximately 2 mins, DIT began to precipitate 
out of solution.  This trial assay was repeated at pH 6.5 with a similar precipitation 
observed after approximately 5 mins. Therefore, we were unable to test the pH 
dependence of substrate binding on 2-deoxyhIYD.  
The second method used to test the importance of the 2ʹOH hydrogen bond for 
substrate binding involved use of the substrate analog, OMeMIT. As an aromatic 
ether, OMeMIT is not capable of forming a phenolate via deprotonation. If the 
phenolate form is indeed necessary for substrate binding in hIYD, it was expected 




no preference should exist, therefore OMeMIT was expected to retain some level of 
binding.  
Equilibrium binding of OMeMIT was performed for both native hIYD and 2-
deoxyhIYD. For native hIYD, a slight drop in fluorescence was observed but only at 
a final OMeMIT concentration greater than 5 mM (Figure 4.4A). This observation 
was right in line with the hypothesis that the inability of OMeMIT to form a 
phenolate would inhibit its binding to native hIYD. More interesting was the 
observation that OMeMIT did not decrease flavin fluorescence in 2-deoxyhIYD 
(Figure 4.4B). Removal of the ribityl 2ʹOH should have eliminated the preference for 
the phenolate form of the substrate. In addition, the slight increase of the active site 
binding pocket due to the absence of the 2ʹOH should allow for small variations in 
substrate. This result may indicate that there is another factor necessary for substrate 
binding. A suggested hydrogen bond between the MIT phenol group and the amide 
backbone of Ala126 in mIYD may also play a role in substrate binding 63. In MCAD, 
the thioester carbonyl oxygen of acyl-CoA is believed to share hydrogen bonds with 
both the 2ʹOH of FAD and a Glu376 residue 26. The cumulative effect of these 
interactions that have been assumed to be responsible for lower the α proton pKa in 
acyl-CoA 27. Similarly in IYD, hydrogen bonds between the phenol group of MIT to 
both the FMN 2ʹOH and Ala126 may be necessary for substrate binding and 






















Figure 4.4 Equilibrium binding of OMeMIT to A) native hIYD and B) 2-deoxyhIYD. 
Binding was monitored by the change in fluorescence of flavin bound to enzyme (4.5 
μM) in solution of 100 mM postassium phosphate and 200 mM postassium chloride 
(pH 7.4) at 25°C using λex of 450 nm and λem of 527 nm 
 
4.2.3 2-DeoxyhIYD does not Support Turnover of OMeMIT 
The currently proposed mechanism for the reductive dehalogenation of MIT by 
hIYD involves substrate tautomerization to an electron deficit keto-intermediate 46. 
To investigate the formation of the proposed intermediate, OMeMIT was used. 
OMeMIT is unable to tautomerize to the non-aromatic ketone. Therefore turnover of 
this analog should not be observed. Although binding of this substrate was not 
observed for either hIYD or 2-deoxyhIYD, these studies were still attempt. For 2-
deoxyhIYD a > 4,000 fold decreased in affinity for MIT did not hinder deiodinase 
activity in the enzyme. Additional, deiodination in 2-deoxyhIYD may occur via a 2 
electron process, as the 2-deoxyFlsq was not detected during anaerobic reduction of 
the enzyme. These factors taken into consideration, we believed it could be possible 
for 2-deoxyhIYD to turnover OMeMIT, even though substrate binding was not 





Deiodination of OMeMIT as monitored by HPLC, showed no formation of the 
OMeTyr product after 4 hours with either native hIYD or 2-deoxyhIYD (Figure 4.5). 
These observations were confirmed by the addition of 10 μM OMeTyr to the reaction 
mixture. The lack of turnover may be the result of hIYD and 2-deoxyhIYD’s inability 
to efficiently bind substrate.  Further studies, possibly with other substrate mimics, 






























Figure 4.5 HPLC chromatograph of the deiodination of OMeMIT by A) 4.5 μM 
hIYD and B) 4.5 μM 2-deoxyhIYD using a 45 min linear gradient from 100% TEAA 
pH 5.5 to 45% acetonitrile. Production formation was monitored at 274 nm. Reaction 
were conducted for 4 hr and spiked with 10 μM OMeTyr to confirm no turnover had 







Anaerobic titrations of 2-deoxyhIYD carried out in the absence and presence of 
MFT resulted in the direct transformation of 2-deoxyFlox to the fully reduced 2-
deoxyFlhq.  2-deoxyFlsq was not detected, suggesting that the 2ʹ-OH may play a role in 
stabilizing the Flsq formed during catalysis in hIYD. Due to the insolubility of 
substrate at low pH, determination of the pH dependence on DIT binding in 2-
deoxyhIYD could not be performed. Binding and turnover studies conducted with 
OMeMIT, showed that neither native hIYD nor 2-deoxyhIYD to have an affinity 
towards this substrate analog. Similarly, neither enzyme was able to support 
enzymatic turnover of the analog. These results, though they may indicate a 
requirement for substrate tautomerzation and therefore phenolate formation, will need 




Biochemical reagents including xanthine oxidase were purchased from Sigma 
Chemicals and used without purification unless specified. 3-Fluoro-L-tyrosine was 
purchased from Astatech, Inc. O-methyl-tyrosine was purchased from Bachem. O-
methyl-3-iodo-L-tyrosine was synthesized by Qi Su. 
4.4.1 Anaerobic Redox Titration  
Redox titrations were performed at 25°C using xanthine/xanthine oxidase as 
the reducing system 90. Individual samples within sealable quartz cuvettes (1.2 mL 
total volume) contained 100 mM potassium phosphate pH 7.4, 200 mM KCl, 900 μM 




flushing with argon for at least 1 hour, prior to addition of 15 μM hIYD. Reaction 
solutions were then purged for an addition 30 minutes, prior to initiation by addition 
of 40 μg/mL xanthine oxidase. Argon flow was maintained over the head space for 
the duration of the reaction. Spectra changes were monitored every 2 minutes for over 
2 hours. Titrations were repeated in the presence of MFT (0.6 mM for hIYD, 5 mM 
for 2-deoxyhIYD) to investigate the effects of ligand binding on the oxidation-
reduction properties of the enzyme-bound FMN. 
4.4.2 Fluorescence Binding 
Substrate dissociation constants for OMeMIT were calculated based on the change in 
fluorescence of enzyme bound flavin upon titration of substrate as described in 
Chapter 3, 
4.4.3 HPLC Deiodinase Activity Assay of OMeMIT 
Catalytic deiodination of OMeMIT as measured by formation of OMeTyr as 




Chapter 5: Conclusions 
The chemical diversity of riboflavin has been extended through its derivatives 
FMN and FAD to a large number of biological processes via nature’s use of 
flavoenzymes. This diversity includes the ability to catalyze both 1 and 2 electron 
redox processes as well as the activation of dioxygen. In flavoenzymes, the 
modulation of flavin chemistry can be attributed to protein-cofactor interactions such 
as hydrogen bonding and π-stacking 8, 11. In order to determine which interactions are 
most important for enzymatic activity, methods like site-directed mutagenesis and 
enzymatic reconstitution with modified flavin have been utilized.  
IYD is critical for proper thyroid function through its salvage of iodide from 
MIT and DIT. As one of the few flavoenzymes capable of supporting reductive 
dehalogenation, no literature precedence for its mechanism has been reported. 
Advances in heterologous expression of IYD in E. coli have resulted in the large scale 
production of IYD for mechanistic studies 62. Detection of the Flsq intermediate 
during anaerobic reduction of IYD in the presence of substrate suggests deiodination 
occurs via a two sequential single electron transfer processes 64, 68. Currently proposed 
1 electron mechanisms for IYD involving formation of a substrate keto-tautomer 46 
are supported by the enzyme’s apparent preference for the phenolate form of substrate 
during binding 64. Analysis of a co-crystal of IYD and MIT show the involvement of 
substrate in extensive interactions with the FMN cofactor, including a hydrogen bond 
between the FMN ribityl 2ʹ-OH and the phenolate of MIT 63. This hydrogen bond has 
been hypothesized to activate substrate for deiodination by facilitating formation of 




substrate recognition. The goal of this dissertation was to synthesis and enzymatically 
phosphorylate 2-deoxyriboflavin for reconstitution with hIYD to probe how 
disruption of this hydrogen bond affects enzyme behavior. 
Removal of the FMN ribityl 2ʹ-OH was observed to significantly decrease 
substrate binding affinity but did not inhibit deiodinase activity. The Flsq was not 
detected during anaerobic reduction of 2-deoxyhIYD in the presence of MFT. Crystal 
structures of IYD show the ribityl 2ʹ-OH to be within 3.3 Å of N1 63. This distance 
suggests possible formation of a hydrogen bond that may be necessary to promote 1 
electron redox chemistry. Further studies will need to be conducted to confirm 
whether deiodination proceeds via a 1 or 2 electron transfer process. Reconstitution of 
hIYD with the 1-and 5-deazaFMN analogs should be helpful in this regard. 1-
deazaFMN, while still able to promote both 1 and 2 electron transfers disrupts the 
hydrogen bond to the ribityl 2ʹ-OH, clarifying the significance of this possible 
interaction 18. 5-deazaFMN can only support 2 electron transfers 18. Therefore this 
analog would clearly distinguish between the proposed 1 electron deiodination 
mechanism and a 2 electron mechanism. The enzyme’s preference for the phenol 
versus phenolate form of substrate could not be determined due to the low solubility 
of halotyrosines at concentrations necessary for fluorescence quenching. However, 2-
deoxyhIYD was shown to not support turnover of OMeMIT, possibly suggesting a 
requirement for substrate tautomerization and therefore a preference for the phenolate 
form of MIT.  
Investigations into the requirements for substrate recognition and activation 




would be helpful in gaining more insights on the mechanism of deiodination.  
Additionally, IYD has been shown to have a propensity to dehalogenation of bromo- 
and chlorotyrosines, broadening the substrate specificity this enzyme 68. If the 
substrate scope for IYD could be expanded to include haloaromatics the enzyme may 
have an application in the area of bioremeditation 91, 92. In order to tap into this 





Appendix A. Supporting Information for Chapter 2 
Figure A.11H NMR of 2-Deoxyribitylated-3,4-dimethylaniline (2.2) taken in d4-
MeOD. 
Figure A.2 ESI+- MS of 2-Deoxyribitylated-3,4-dimethylaniline (2.2) (m/z) [M+H]+ 




Figure A.3 1H NMR of crude Diazo-2-Deoxyribitylated-3,4-Dimethylaniline (2.3) 























Figure A.5 ESI+- MS for Diazo-2-Deoxyribitylated-3,4-Dimethylaniline (2.3)  (m/z) 





























Figure A.7 UPLC- MS for 2-Deoxyriboflavin (m/z) [M+H] + for C17H20N4O5 




Figure A.8 1H NMR of 2-DeoxyFMN taken in D2O. 
 
 
Figure A.9 UPLC- MS for 2-DeoxyFMN (m/z) [M+H] + for C17H20N4O5 calculated: 







Appendix B. Supporting Information for Chapter 3 
 
Figure B.1 Equilibrium binding of DIT to 2-deoxyhIYD.   
 
DIT binding was monitored by the change in fluorescence of flavin bound to 
hIYD (4.5 μM) in solution of 100 mM postassium phosphate and 200 mM postassium 
chloride (pH 7.4) at 25°C using λex of 450 nm and λem of 527 nm. The average of 
three independent measurements were normalized and plotted against DIT 
concentrations. Error represents the standard deviation of three measurements. A 
dissociation constant of 5.03 ± 0.16 mM was obtained by nonlinear fitting of the data 


























Figure B.2. Time Course MIT deiodinase activity of 2-deoxyhIYD. 
 
The deiodination of MIT by 2-deoxyhIYD (0.4 μM) was monitored by HPLC 
as described in Chapter 3 from 0 – 4 hours. The increase of tyrosine formation, as 
determined by the increase area of the tyrosine signal, was plotted against time and fit 




Figure B.3.  D
125
IT deiodinase activity of 2-deoxyhIYD. 
 
The activity of 2-deoxyhIYD (0.4 μM) with DIT was determined using the 
standard D
125
IT iodide release assay. Assays were performed in triplicate. Kinetic 
constants were obtained by fitting the average of the three independent measurements 
to Michaelis-Menten kinetics using Origin 7.0. Error bars represent standard 
deviation at each concentration. The kinetic parameter obtained from the fitting was a 



























Figure B.4.  Standard Curve of Tyrosine. 
The standard curve of tyrosine was used to calculate reaction rates for the 
MIT deiodination assay monitored by HPLC as described in Chapter 3.  The 
calibration curve was generated by injection of known amount of tyrosine and phenol 
onto the HPLC 86. Measurements were performed in duplicate and the average of the 
two trials were normalized and plotted against tyrosine concentrations. Error 
represents the standard deviation of two measurements. RF was calculated using 





Appendix C.  Supporting Information for Chapter 4 
 
Figure C.1. Equilibrium binding of MFT to 2-deoxyhIYD.   
 
MFT binding was monitored by the change in fluorescence of flavin bound to 
hIYD (4.5 μM) in solution of 100 mM postassium phosphate and 200 mM postassium 
chloride (pH 7.4) at 25°C using λex of 450 nm and λem of 527 nm. A dissociation 
constant of 1.49 ± 0.07 mM obtained by nonlinear fitting of the data to Eq. 3.1 by 
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